You have 9 free searches left this month | for more free features.

Vidarabine

Showing 26 - 50 of 93

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • Fludarabine and Busulfan
  • Fludarabine and Melphalan
  • Wuhan, Hubei, China
    Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
Jan 5, 2023

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Duarte (procedure, drug, other)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Nov 2, 2021

Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford

Recruiting
  • Allogeneic Hematopoietic Cell Transplantation (HCT)
  • +5 more
  • Purified regulatory T-cells (Treg) plus CD34+ HSPC
  • +7 more
  • Stanford, California
    Stanford University
Oct 28, 2021

Diffuse Large B Cell Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Wuhan (BTK inhibitor+ Fludarabine +

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • BTK inhibitor+ Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
  • Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
  • Wuhan, Hubei, China
    Union Hospital, Huazhong University of Science and Technology
Oct 13, 2021

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Morgantown (Busulfan, Fludarabine)

Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • Morgantown, West Virginia
    West Virginia University Hospitals Mary Babb Randolph Cancer Cen
Apr 6, 2021

Non-Hodgkin's Lymphoma Trial in United States (fludarabine and rituximab, fludarabine, rituximab, pixantrone)

Withdrawn
  • Non-Hodgkin's Lymphoma
  • fludarabine and rituximab
  • fludarabine, rituximab, pixantrone
  • Muscle Shoals, Alabama
  • +7 more
Oct 2, 2020

Hematopoietic and Lymphoid Cell Tumor, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +13 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 8, 2022

Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Recurrent Myeloproliferative Tumor Trial in Chicago

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • +4 more
  • Chicago, Illinois
    Northwestern University
Mar 26, 2021

Multiple Myeloma Trial in New York (busulfan, melphalan and fludarabine)

Completed
  • Multiple Myeloma
  • busulfan, melphalan and fludarabine
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 4, 2021

Melanoma Trial in Stockholm (Cyclophosphamide, Fludarabine, T cells)

Recruiting
  • Melanoma
  • Stockholm, Sweden
    Karolinska University Hospital
Sep 17, 2020

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +46 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 10, 2021

Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Chicago (Fludarabine-Melphalan & Rabbit antithymocyte globulin

Completed
  • Leukemia
  • +3 more
  • Fludarabine-Melphalan & Rabbit antithymocyte globulin (r-ATG)
  • +4 more
  • Chicago, Illinois
    The University of Chicago
Jan 8, 2021

Myelofibrosis Trial in Italy (A: Fludarabine + Busulphan, B: Fludarabine + Thiotepa)

Completed
  • Myelofibrosis
  • A: Fludarabine + Busulphan
  • B: Fludarabine + Thiotepa
  • Alessandria, Italy
  • +20 more
Aug 19, 2021

Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,

Completed
  • Disorder Related to Bone Marrow Transplantation
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 18, 2021

Acute Myeloid Leukaemia Trial in Worldwide (Gemtuzumab ozogamicin, Liposomal daunorubicin, Mitoxantrone)

Recruiting
  • Acute Myeloid Leukaemia
  • Gemtuzumab ozogamicin
  • +6 more
  • Adelaide, Australia
  • +67 more
Sep 30, 2021

Stem Cell Transplantation, Leukemia Trial in Houston (Fludarabine, Busulfan, Thymoglobulin)

Completed
  • Stem Cell Transplantation
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 21, 2021

Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell

Active, not recruiting
  • Leukemia
  • +9 more
  • Fludarabine monophosphate
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 2, 2020

Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood Trial in Australia, Canada, United States

Completed
  • Lymphoblastic Leukemia, Acute, Childhood
  • Myelogenous Leukemia, Acute, Childhood
  • Los Angeles, California
  • +22 more
May 14, 2021

Metastatic Melanoma Trial run by the National Cancer Institute (NCI) (Aldesleukin, Fludarabine, Cyclophosphamide)

Completed
  • Metastatic Melanoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 21, 2022

Leukemia, Lymphoma Trial in Houston (drug, radiation, procedure)

Completed
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2021

Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis Urothelial Carcinoma, Metastatic Ureter Urothelial Carcinoma

Withdrawn
  • Metastatic Bladder Urothelial Carcinoma
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 27, 2019

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) Trial in United States

Completed
  • Acute Myeloid Leukemia (AML)
  • +3 more
  • Phoenix, Arizona
  • +5 more
Mar 25, 2020

Neuroblastoma Trial in Houston (Fludarabine, Cyclophosphamide, Natural Killer Cell Infusion)

Terminated
  • Neuroblastoma
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

Blood And Marrow Transplantation, Leukemia, Lymphoma Trial (Cyclophosphamide, Fludarabine, T-Cell Infusion)

Withdrawn
  • Blood And Marrow Transplantation
  • +2 more
  • (no location specified)
Jan 17, 2020